MicroRNA-877 Contributes to Decreased Non-small Cell Lung Cancer Cell Growth Via the PI3K/AKT Pathway by Targeting Tartrate Resistant Acid Phosphatase 5 Activity

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2020 Nov 23

PMID 33222607

Citations 4

Authors

Xue Bai

Changjun He

Bicheng Fu

Xianglong Kong

Jianlong Bu

Kaibin Zhu

Wei Zheng

Fucheng Zhou

Boxiong Ni

Affiliations

Soon will be listed here.

Abstract

Non-small cell lung cancer (NSCLC) is a leading cause of cancer death in both men and women. microRNAs (miRs) can exert important functions in cancer development. However, the role of miR-877 in NSCLC as it relates to tartrate resistant acid phosphatase 5 (ACP5) is unknown. For this study, the gain-and-loss-of-function experiments were performed to explore the effects of miR-877 and ACP5 on NSCLC. miR-877 expression in LC and paracancerous tissues, lung epithelial cell line and NSCLC cell lines was detected, and the association between miR-877 expression and clinical features of LC patients was analyzed. The levels of ACP5, epithelial-mesenchymal transition (EMT) markers and apoptosis-related proteins were measured. experiments were conducted for further validation. Consequently, we found that miR-877 expression was lowered in LC tissues and cell lines, and correlated with clinical stage, differentiation, lymph node metastasis and prognosis of NSCLC patients. Additionally, miR-877 was determined to inhibit ACP5 activity, and miR-877 downregulated the PI3K/AKT pathway by silencing ACP5. Furthermore, overexpression of miR-877 inhibited the viability, migration, invasion and EMT of NSCLC cells, but promoted cell apoptosis. In conclusion, miR-877 overexpression inhibited malignant biological behaviors of NSCLC cells by downregulating ACP5 and inactivating the PI3K/AKT pathway.

Citing Articles

Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study.

Petracci E, Pasini L, Urbini M, Felip E, Stella F, Davoli F J Exp Clin Cancer Res. 2024; 43(1):241.

PMID: 39169404 PMC: 11340091. DOI: 10.1186/s13046-024-03156-y.

Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction.

Yang S, Pei L, Huang Z, Zhong Y, Li J, Hong Y Mol Med. 2024; 30(1):89.

PMID: 38879488 PMC: 11179352. DOI: 10.1186/s10020-024-00856-1.

A Comprehensive Study on Signal Transduction and Therapeutic Role of miR-877 in Human Cancers.

Rafat M, Kohsarian M, Bahiraei M, Nikpoor A Adv Biomed Res. 2023; 12:118.

PMID: 37434921 PMC: 10331537. DOI: 10.4103/abr.abr_412_21.

Splice and Dice: Intronic microRNAs, Splicing and Cancer.

Wong A, Rasko J Biomedicines. 2021; 9(9).

PMID: 34572454 PMC: 8465124. DOI: 10.3390/biomedicines9091268.

References

Bach P, Mirkin J, Oliver T, Azzoli C, Berry D, Brawley O . Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307(22):2418-29. PMC: 3709596. DOI: 10.1001/jama.2012.5521. View

Yamashita N, Tokunaga E, Iimori M, Inoue Y, Tanaka K, Kitao H . Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer. Clin Breast Cancer. 2018; 18(5):e1003-e1009. DOI: 10.1016/j.clbc.2018.02.002. View

Wang C, Gu S, Cao H, Li Z, Xiang Z, Hu K . miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis. Sci Rep. 2016; 6:30122. PMC: 4957095. DOI: 10.1038/srep30122. View

Yao Z, Fenoglio S, Gao D, Camiolo M, Stiles B, Lindsted T . TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc Natl Acad Sci U S A. 2010; 107(35):15535-40. PMC: 2932568. DOI: 10.1073/pnas.1009472107. View

Shen J, Liao J, Guarnera M, Fang H, Cai L, Stass S . Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis. J Thorac Oncol. 2013; 9(1):33-40. PMC: 4967496. DOI: 10.1097/JTO.0000000000000025. View

Luo W, Huang B, Li Z, Li H, Sun L, Zhang Q . MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met. PLoS One. 2013; 8(5):e64759. PMC: 3667122. DOI: 10.1371/journal.pone.0064759. View

Torre L, Siegel R, Jemal A . Lung Cancer Statistics. Adv Exp Med Biol. 2015; 893:1-19. DOI: 10.1007/978-3-319-24223-1_1. View

Othman N, In L, Harikrishna J, Hasima N . Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells. PLoS One. 2013; 8(12):e81735. PMC: 3858247. DOI: 10.1371/journal.pone.0081735. View

Fajersztajn L, Veras M, Barrozo L, Saldiva P . Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer. 2013; 13(9):674-8. DOI: 10.1038/nrc3572. View

10.

Myong N . Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression. Korean J Pathol. 2012; 46(4):341-8. PMC: 3479821. DOI: 10.4132/KoreanJPathol.2012.46.4.341. View

11.

Wang X, Qiu H, Tang R, Song H, Pan H, Feng Z . miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1. Oncol Rep. 2018; 39(6):2635-2643. PMC: 5983935. DOI: 10.3892/or.2018.6379. View

12.

Chen M, Du Y, Qui M, Wang M, Chen K, Huang Z . Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncol Rep. 2012; 29(2):430-6. PMC: 3583607. DOI: 10.3892/or.2012.2131. View

13.

Li C, Lyu J, Meng Q . MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of //. J Cancer. 2017; 8(5):870-879. PMC: 5381176. DOI: 10.7150/jca.17958. View

14.

Mulherkar R, Grewal A, Berman A . Emerging role of immunotherapy in locally advanced non-small cell lung cancer. Clin Adv Hematol Oncol. 2020; 18(4):212-217. View

15.

Cui R, Kim T, Fassan M, Meng W, Sun H, Jeon Y . MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. 2015; 6(26):21802-15. PMC: 4673127. DOI: 10.18632/oncotarget.5224. View

16.

Zarogoulidis P, Baka S, Labaki S, Lazaridis G, Trakada G . Targeted Lung Cancer Treatments and Eye Metastasis. Med Hypothesis Discov Innov Ophthalmol. 2017; 6(1):10-13. PMC: 5392227. View

17.

Xu P, Cai X, Zhang W, Li Y, Qiu P, Lu D . Flavonoids of Rosa roxburghii Tratt exhibit radioprotection and anti-apoptosis properties via the Bcl-2(Ca(2+))/Caspase-3/PARP-1 pathway. Apoptosis. 2016; 21(10):1125-43. DOI: 10.1007/s10495-016-1270-1. View

18.

Shi Q, Xu X, Liu Q, Luo F, Shi J, He X . MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma. Oncol Lett. 2016; 11(2):1474-1480. PMC: 4734253. DOI: 10.3892/ol.2015.4072. View

19.

Halling Linder C, Ek-Rylander B, Krumpel M, Norgard M, Narisawa S, Millan J . Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone Mineralization. Calcif Tissue Int. 2017; 101(1):92-101. PMC: 5486932. DOI: 10.1007/s00223-017-0259-2. View

20.

Huang X, Qin J, Lu S . Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1. Int J Clin Exp Pathol. 2015; 8(2):1515-24. PMC: 4396225. View